Eurepa 2mg contains repaglinide 2mg, a meglitinide-class medicine that stimulates insulin secretion from functioning pancreatic beta cells. Its relatively rapid and short-lived action makes it particularly associated with glucose control around meals.

Repaglinide dosing is closely connected with meals, making adherence to the prescribed meal schedule an important part of treatment. It may be used alone or alongside other glucose-lowering medicines where appropriate.

Brand: Eurepa

Active Ingredient: Repaglinide

Strength: 2mg

Dosage Form: Tablet

Pack Size: 15 tablets

Class: Meglitinide

Route: Oral

Take only according to the prescribed instructions, particularly regarding meals.